Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01906346 · ClinicalTrials.gov registry record · Early Phase 1
Impact of a Non-Drug Choice on Cocaine Reinforcement
A Early Phase 1 study, sponsored by Joshua A. Lile, Ph.D..
- Completed
- Registry status
- Early Phase 1
- Development phase
- 9
- Enrollment target
NCT01906346 is a Early Phase 1 study that has completed, run by Joshua A. Lile, Ph.D.. The registered enrollment target is 9 participants.
The verdict
NCT01906346, a Early Phase 1 study, has completed, sponsored by Joshua A. Lile, Ph.D..
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
Cocaine-use disorders continue to be a significant public health concern, yet no effective medications have been identified. The goal of this study is to establish a research platform for the development of medications for treatment of cocaine abuse and dependence. This study will incorporate self-administration procedures and a non-drug alternative reinforcer, which is hypothesized to reduce the reinforcing effects of cocaine.
Interventions
- DRUG Placebo
- DRUG Cocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2014-01 |
| Est. Completion | 2015-06 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01906346
The ClinicalTrials.gov registry entry for NCT01906346 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Joshua A. Lile, Ph.D., which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01906346 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01906346 about?
NCT01906346 is a clinical study titled "Impact of a Non-Drug Choice on Cocaine Reinforcement". Cocaine-use disorders continue to be a significant public health concern, yet no effective medications have been identified. The goal of this study is to establish a research platform for the development of medications for treatment of cocaine abuse and dependence. This study will incorporate self-a...
What is the current status of trial NCT01906346?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 9 participants. The study started on 2014-01. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01906346?
The interventions under investigation include: Placebo (DRUG), Cocaine (DRUG).
Who is sponsoring clinical trial NCT01906346?
This trial is sponsored by Joshua A. Lile, Ph.D., which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.